Skip to main content
. 2016 Jan 15;8(1):128–135. doi: 10.4251/wjgo.v8.i1.128

Table 3.

RAS and BRAF status and carcinoembryonic antigen levels

BRAF BRAF P RAS RAS P
All
MT
WT
MT
WT
n % n % n % n % n %
< 5 ng/mL 60 34 4 7 56 93 1.00 37 62 23 38 0.037
≥ 5 ng/mL 114 66 7 6 107 94 64 56 50 44

n: Number of patients; MT: Mutant; WT: Wild type.